
University College London – Translational Research Office
Keywords: ADVANCED THERAPY; ASSAY BIOLOGY; BIOLOGIC; BIOMEDICAL TRANSLATION; BUSINESS PARTNERSHIP; COMPANY ENGAGEMENT; DEVICE; DIAGNOSTIC; DRUG DEVELOPMENT; DRUG DISCOVERY; INDUSTRY/ACADEMIA STRATEGIC ALLIANCES; INNOVATION; MEDICINAL CHEMISTRY; PRECLINICAL TO EARLY PHASE CLINICAL TRANSLATION; PROJECT LEADERSHIP; REPURPOSING; RESEARCH PROJECT MANAGEMENT; SMALL MOLECULE; STRATEGIC ALLIANCES; THERAPEUTICS; TRANSLATIONAL RESEARCH OFFICE; TRO; UCL; UNIVERSITY COLLEGE LONDON
Document Type: Research Article
Publication date: December 1, 2018
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites